We are currently undertaking a range of research projects and trials including :

• PRoBaND: Parkinsons Repository of Biosamples and Network Datasets
• PANDA - OXN PR for severe PD associated pain
• CSF in Patients with Normal Pressure Hydrocephalus
• Efficacy of safety of 3 doses of S 38093 (2, 5 and 20 mg/day) versus placebo, in co-administration with donepexil (210 mg/day) in patients with moderate Alzheimer's disease
• Genetic Analysis of Multiple Sclerosis
• Progas (A Prospective Multi-Centre Evaluation of Gastrostomy in Patients with Motor Neurone Disease)
• Euro-HD Registry (Huntington’s Disease)

Studies planned for the future include :

• Trajectories of Outcome in Neurological Conditions: Quality of Life (QoL) and neurological disease
• GSK1223249, anti-NOGO-A monoclonal antibody - NOG112264 study in motor neurone disease